D. E. Shaw & Co., Inc. Generation Bio Co. Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
Shares
17 transactions
Others Institutions Holding GBIO
# of Institutions
58Shares Held
40.9MCall Options Held
116KPut Options Held
0-
Price T Rowe Associates Inc Baltimore, MD8.46MShares$34.3 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$33.5 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$13.3 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.97MShares$12 Million0.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.58MShares$10.5 Million0.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $239M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...